Health Canada Approves First Disease-Modifying Drug for Alzheimer’s Disease Health Canada has granted conditional authorization for lecanemab, a new antibody drug designed to slow the progression of Alzheimer’s disease in …
@2025 – Hosted by ByoHosting – Most Recommendeed Webhhosting. For complains, abuse, advertising contact: office@byohosting.com